1 | adult | 15,480 |
2 | one-day-old | 80 |
3 | 1-d-old | 61 |
4 | aphasic | 46 |
5 | neutered | 40 |
6 | 8-week-old | 26 |
7 | 6-week-old | 23 |
8 | eight-week-old | 21 |
9 | aripiprazole-treated | 20 |
10 | unpremedicated | 18 |
11 | age-eligible | 16 |
12 | bladder-drained | 15 |
13 | sardinian | 15 |
14 | antidepressant-free | 12 |
15 | influenza-infected | 12 |
16 | marker-positive | 12 |
17 | e2-treated | 11 |
18 | four-week-old | 11 |
19 | mechanically-ventilated | 11 |
20 | methotrexate-naive | 11 |
21 | 21-d-old | 10 |
22 | asthenozoospermic | 10 |
23 | penicillin-treated | 10 |
24 | anthracycline-treated | 9 |
25 | bpa-exposed | 9 |
26 | diatel | 9 |
27 | hyperphagic | 9 |
28 | one-d-old | 9 |
29 | 5,887 | 8 |
30 | desvenlafaxine-treated | 8 |
31 | 6-wk-old | 7 |
32 | nicotine-treated | 7 |
33 | solid-tumor | 7 |
34 | 2774 | 6 |
35 | chinese-han | 6 |
36 | combination-treated | 6 |
37 | efv-treated | 6 |
38 | glyburide-treated | 6 |
39 | pasteurizing | 6 |
40 | 1,541 | 5 |
41 | 1,763 | 5 |
42 | 1,775 | 5 |
43 | 20,127 | 5 |
44 | 5887 | 5 |
45 | 7-wk-old | 5 |
46 | 8-wk-old | 5 |
47 | archean | 5 |
48 | five-week-old | 5 |
49 | formalin-preserved | 5 |
50 | lasercomb-treated | 5 |
51 | late-presenting | 5 |
52 | premenarcheal | 5 |
53 | silodosin-treated | 5 |
54 | three-week-old | 5 |
55 | 14,641 | 4 |
56 | 14-16-year-old | 4 |
57 | 2,436 | 4 |
58 | 30-day-old | 4 |
59 | 3154 | 4 |
60 | 4777 | 4 |
61 | 9298 | 4 |
62 | adult/adolescent | 4 |
63 | cannabis-using | 4 |
64 | cbt-treated | 4 |
65 | cyclosporin-treated | 4 |
66 | eptifibatide-treated | 4 |
67 | fluvoxamine-treated | 4 |
68 | infibulated | 4 |
69 | kaf | 4 |
70 | kaiser-permanente | 4 |
71 | lhbt-positive | 4 |
72 | noncircumcised | 4 |
73 | subadult | 4 |
74 | tg-misiir-tag | 4 |
75 | 1,894 | 3 |
76 | 2,370 | 3 |
77 | 240-kg | 3 |
78 | 3274 | 3 |
79 | 3734 | 3 |
80 | 42-d-old | 3 |
81 | 4594 | 3 |
82 | 48,612 | 3 |
83 | 5228 | 3 |
84 | 55-kg | 3 |
85 | 7052 | 3 |
86 | 8245 | 3 |
87 | adr-treated | 3 |
88 | arsenic-exposed | 3 |
89 | blackface | 3 |
90 | children.the | 3 |
91 | community-treated | 3 |
92 | conventionally-treated | 3 |
93 | deslorelin-treated | 3 |
94 | doxazosin-treated | 3 |
95 | hepatolithiatic | 3 |
96 | hiv/hcv-co-infected | 3 |
97 | nnk-treated | 3 |
98 | non-binge-drinking | 3 |
99 | non-immunised | 3 |
100 | non-paralyzed | 3 |
101 | non-tribal | 3 |
102 | non-vomiting | 3 |
103 | ozp-treated | 3 |
104 | preirradiated | 3 |
105 | restricting-type | 3 |
106 | se-positive | 3 |
107 | semi-acute | 3 |
108 | short-necked | 3 |
109 | 10,987 | 2 |
110 | 11,997 | 2 |
111 | 129s1/svimj | 2 |
112 | 19,368 | 2 |
113 | 2,259 | 2 |
114 | 2,909 | 2 |
115 | 20,165 | 2 |
116 | 2753 | 2 |
117 | 3,533 | 2 |
118 | 3051 | 2 |
119 | 32-wk-old | 2 |
120 | 4,425 | 2 |
121 | 4,778 | 2 |
122 | 6644 | 2 |
123 | 7,277 | 2 |
124 | 7,600 | 2 |
125 | 7,866 | 2 |
126 | 8584 | 2 |
127 | 87,222 | 2 |
128 | 8808 | 2 |
129 | 8923 | 2 |
130 | 9650 | 2 |
131 | agonadal | 2 |
132 | anti-tnf-naive | 2 |
133 | baipc-treated | 2 |
134 | bilaterian | 2 |
135 | bradykinin-treated | 2 |
136 | daywork | 2 |
137 | flutamide-exposed | 2 |
138 | groups.all | 2 |
139 | head-trauma | 2 |
140 | hrv-infected | 2 |
141 | ht-treated | 2 |
142 | intersubspecific | 2 |
143 | itt2 | 2 |
144 | lamotrigine-treated | 2 |
145 | low-uti-risk | 2 |
146 | non-dysphagic | 2 |
147 | non-immune-suppressed | 2 |
148 | non-ma-treated | 2 |
149 | non-naive | 2 |
150 | non-organized | 2 |
151 | non-steroid-dependent | 2 |
152 | noninfant | 2 |
153 | nonsystolic | 2 |
154 | overnight-abstinent | 2 |
155 | people.the | 2 |
156 | practitioner-referred | 2 |
157 | propofol-anesthetized | 2 |
158 | psychoneurotic | 2 |
159 | screen-eligible | 2 |
160 | sham-group | 2 |
161 | statin-exposed | 2 |
162 | volume-depleted | 2 |
163 | white-asian | 2 |
164 | women-safe | 2 |
165 | 112528 | 1 |
166 | 12,032 | 1 |
167 | 12,639 | 1 |
168 | 15/277 | 1 |
169 | 18,409 | 1 |
170 | 18,693 | 1 |
171 | 18-28-yr-old | 1 |
172 | 180-day-old | 1 |
173 | 188,503 | 1 |
174 | 19,439 | 1 |
175 | 21,054 | 1 |
176 | 226,866 | 1 |
177 | 27,111 | 1 |
178 | 275,831 | 1 |
179 | 28045 | 1 |
180 | 29,592 | 1 |
181 | 3,769 | 1 |
182 | 3-4-month-old | 1 |
183 | 3.5-wk | 1 |
184 | 328,398 | 1 |
185 | 32:5 | 1 |
186 | 37,724 | 1 |
187 | 4,936 | 1 |
188 | 425-gram | 1 |
189 | 51,048 | 1 |
190 | 5699 | 1 |
191 | 6-8-month-old | 1 |
192 | 6-day-old | 1 |
193 | 6109 | 1 |
194 | 612,851 | 1 |
195 | 67,784 | 1 |
196 | 75-day-old | 1 |
197 | 76,591 | 1 |
198 | 76-years-old | 1 |
199 | 7839 | 1 |
200 | 8.5-year-old | 1 |
201 | 81-yr-old | 1 |
202 | 82-y-old | 1 |
203 | 886-g | 1 |
204 | 92,071 | 1 |
205 | africanamerican | 1 |
206 | aht/hc | 1 |
207 | b6cbf1 | 1 |
208 | bedouin-arab | 1 |
209 | cap.the | 1 |
210 | children® | 1 |
211 | clopidogrel-pretreated | 1 |
212 | crc-affected | 1 |
213 | deinstitutionalized | 1 |
214 | demand.all | 1 |
215 | diarrhea-positive | 1 |
216 | dorn | 1 |
217 | draw-a-man | 1 |
218 | dysvascular | 1 |
219 | eighteen-year-old | 1 |
220 | eighty-day-old | 1 |
221 | employment-seeking | 1 |
222 | exercise.fourteen | 1 |
223 | first-ami | 1 |
224 | freiberger | 1 |
225 | government-accredited | 1 |
226 | hbeag-seropositive | 1 |
227 | heart-failure-free | 1 |
228 | infirmed | 1 |
229 | low-accuracy | 1 |
230 | lung-anesthetized | 1 |
231 | m/z-negative | 1 |
232 | m/z-positive | 1 |
233 | medicare-supported | 1 |
234 | met30-ttr-fap | 1 |
235 | model+no | 1 |
236 | mother-perinate | 1 |
237 | ncct-deficient | 1 |
238 | new-diagnosed | 1 |
239 | normotensive/pre-hyptertensive | 1 |
240 | pair-bonded | 1 |
241 | palest | 1 |
242 | persons.unlike | 1 |
243 | rigvedic | 1 |
244 | self-labeled | 1 |
245 | spf/vaf | 1 |
246 | trauma-injury | 1 |
247 | trial,80 | 1 |
248 | trimethoprim-treated | 1 |
249 | young-adolescent | 1 |
250 | zoo-raised | 1 |
251 | ~12,000 | 1 |
252 | °c-carbonized | 1 |
1 | 1,541 | 5 |
2 | 1,763 | 5 |
3 | 1,775 | 5 |
4 | 1,894 | 3 |
5 | 1-d-old | 61 |
6 | 10,987 | 2 |
7 | 11,997 | 2 |
8 | 112528 | 1 |
9 | 12,032 | 1 |
10 | 12,639 | 1 |
11 | 129s1/svimj | 2 |
12 | 14,641 | 4 |
13 | 14-16-year-old | 4 |
14 | 15/277 | 1 |
15 | 18,409 | 1 |
16 | 18,693 | 1 |
17 | 18-28-yr-old | 1 |
18 | 180-day-old | 1 |
19 | 188,503 | 1 |
20 | 19,368 | 2 |
21 | 19,439 | 1 |
22 | 2,259 | 2 |
23 | 2,370 | 3 |
24 | 2,436 | 4 |
25 | 2,909 | 2 |
26 | 20,127 | 5 |
27 | 20,165 | 2 |
28 | 21,054 | 1 |
29 | 21-d-old | 10 |
30 | 226,866 | 1 |
31 | 240-kg | 3 |
32 | 27,111 | 1 |
33 | 275,831 | 1 |
34 | 2753 | 2 |
35 | 2774 | 6 |
36 | 28045 | 1 |
37 | 29,592 | 1 |
38 | 3,533 | 2 |
39 | 3,769 | 1 |
40 | 3-4-month-old | 1 |
41 | 3.5-wk | 1 |
42 | 30-day-old | 4 |
43 | 3051 | 2 |
44 | 3154 | 4 |
45 | 32-wk-old | 2 |
46 | 3274 | 3 |
47 | 328,398 | 1 |
48 | 32:5 | 1 |
49 | 37,724 | 1 |
50 | 3734 | 3 |
51 | 4,425 | 2 |
52 | 4,778 | 2 |
53 | 4,936 | 1 |
54 | 42-d-old | 3 |
55 | 425-gram | 1 |
56 | 4594 | 3 |
57 | 4777 | 4 |
58 | 48,612 | 3 |
59 | 5,887 | 8 |
60 | 51,048 | 1 |
61 | 5228 | 3 |
62 | 55-kg | 3 |
63 | 5699 | 1 |
64 | 5887 | 5 |
65 | 6-8-month-old | 1 |
66 | 6-day-old | 1 |
67 | 6-week-old | 23 |
68 | 6-wk-old | 7 |
69 | 6109 | 1 |
70 | 612,851 | 1 |
71 | 6644 | 2 |
72 | 67,784 | 1 |
73 | 7,277 | 2 |
74 | 7,600 | 2 |
75 | 7,866 | 2 |
76 | 7-wk-old | 5 |
77 | 7052 | 3 |
78 | 75-day-old | 1 |
79 | 76,591 | 1 |
80 | 76-years-old | 1 |
81 | 7839 | 1 |
82 | 8-week-old | 26 |
83 | 8-wk-old | 5 |
84 | 8.5-year-old | 1 |
85 | 81-yr-old | 1 |
86 | 82-y-old | 1 |
87 | 8245 | 3 |
88 | 8584 | 2 |
89 | 87,222 | 2 |
90 | 8808 | 2 |
91 | 886-g | 1 |
92 | 8923 | 2 |
93 | 92,071 | 1 |
94 | 9298 | 4 |
95 | 9650 | 2 |
96 | adr-treated | 3 |
97 | adult | 15,480 |
98 | adult/adolescent | 4 |
99 | africanamerican | 1 |
100 | age-eligible | 16 |
101 | agonadal | 2 |
102 | aht/hc | 1 |
103 | anthracycline-treated | 9 |
104 | anti-tnf-naive | 2 |
105 | antidepressant-free | 12 |
106 | aphasic | 46 |
107 | archean | 5 |
108 | aripiprazole-treated | 20 |
109 | arsenic-exposed | 3 |
110 | asthenozoospermic | 10 |
111 | b6cbf1 | 1 |
112 | baipc-treated | 2 |
113 | bedouin-arab | 1 |
114 | bilaterian | 2 |
115 | blackface | 3 |
116 | bladder-drained | 15 |
117 | bpa-exposed | 9 |
118 | bradykinin-treated | 2 |
119 | cannabis-using | 4 |
120 | cap.the | 1 |
121 | cbt-treated | 4 |
122 | children.the | 3 |
123 | children® | 1 |
124 | chinese-han | 6 |
125 | clopidogrel-pretreated | 1 |
126 | combination-treated | 6 |
127 | community-treated | 3 |
128 | conventionally-treated | 3 |
129 | crc-affected | 1 |
130 | cyclosporin-treated | 4 |
131 | daywork | 2 |
132 | deinstitutionalized | 1 |
133 | demand.all | 1 |
134 | deslorelin-treated | 3 |
135 | desvenlafaxine-treated | 8 |
136 | diarrhea-positive | 1 |
137 | diatel | 9 |
138 | dorn | 1 |
139 | doxazosin-treated | 3 |
140 | draw-a-man | 1 |
141 | dysvascular | 1 |
142 | e2-treated | 11 |
143 | efv-treated | 6 |
144 | eight-week-old | 21 |
145 | eighteen-year-old | 1 |
146 | eighty-day-old | 1 |
147 | employment-seeking | 1 |
148 | eptifibatide-treated | 4 |
149 | exercise.fourteen | 1 |
150 | first-ami | 1 |
151 | five-week-old | 5 |
152 | flutamide-exposed | 2 |
153 | fluvoxamine-treated | 4 |
154 | formalin-preserved | 5 |
155 | four-week-old | 11 |
156 | freiberger | 1 |
157 | glyburide-treated | 6 |
158 | government-accredited | 1 |
159 | groups.all | 2 |
160 | hbeag-seropositive | 1 |
161 | head-trauma | 2 |
162 | heart-failure-free | 1 |
163 | hepatolithiatic | 3 |
164 | hiv/hcv-co-infected | 3 |
165 | hrv-infected | 2 |
166 | ht-treated | 2 |
167 | hyperphagic | 9 |
168 | infibulated | 4 |
169 | infirmed | 1 |
170 | influenza-infected | 12 |
171 | intersubspecific | 2 |
172 | itt2 | 2 |
173 | kaf | 4 |
174 | kaiser-permanente | 4 |
175 | lamotrigine-treated | 2 |
176 | lasercomb-treated | 5 |
177 | late-presenting | 5 |
178 | lhbt-positive | 4 |
179 | low-accuracy | 1 |
180 | low-uti-risk | 2 |
181 | lung-anesthetized | 1 |
182 | m/z-negative | 1 |
183 | m/z-positive | 1 |
184 | marker-positive | 12 |
185 | mechanically-ventilated | 11 |
186 | medicare-supported | 1 |
187 | met30-ttr-fap | 1 |
188 | methotrexate-naive | 11 |
189 | model+no | 1 |
190 | mother-perinate | 1 |
191 | ncct-deficient | 1 |
192 | neutered | 40 |
193 | new-diagnosed | 1 |
194 | nicotine-treated | 7 |
195 | nnk-treated | 3 |
196 | non-binge-drinking | 3 |
197 | non-dysphagic | 2 |
198 | non-immune-suppressed | 2 |
199 | non-immunised | 3 |
200 | non-ma-treated | 2 |
201 | non-naive | 2 |
202 | non-organized | 2 |
203 | non-paralyzed | 3 |
204 | non-steroid-dependent | 2 |
205 | non-tribal | 3 |
206 | non-vomiting | 3 |
207 | noncircumcised | 4 |
208 | noninfant | 2 |
209 | nonsystolic | 2 |
210 | normotensive/pre-hyptertensive | 1 |
211 | one-d-old | 9 |
212 | one-day-old | 80 |
213 | overnight-abstinent | 2 |
214 | ozp-treated | 3 |
215 | pair-bonded | 1 |
216 | palest | 1 |
217 | pasteurizing | 6 |
218 | penicillin-treated | 10 |
219 | people.the | 2 |
220 | persons.unlike | 1 |
221 | practitioner-referred | 2 |
222 | preirradiated | 3 |
223 | premenarcheal | 5 |
224 | propofol-anesthetized | 2 |
225 | psychoneurotic | 2 |
226 | restricting-type | 3 |
227 | rigvedic | 1 |
228 | sardinian | 15 |
229 | screen-eligible | 2 |
230 | se-positive | 3 |
231 | self-labeled | 1 |
232 | semi-acute | 3 |
233 | sham-group | 2 |
234 | short-necked | 3 |
235 | silodosin-treated | 5 |
236 | solid-tumor | 7 |
237 | spf/vaf | 1 |
238 | statin-exposed | 2 |
239 | subadult | 4 |
240 | tg-misiir-tag | 4 |
241 | three-week-old | 5 |
242 | trauma-injury | 1 |
243 | trial,80 | 1 |
244 | trimethoprim-treated | 1 |
245 | unpremedicated | 18 |
246 | volume-depleted | 2 |
247 | white-asian | 2 |
248 | women-safe | 2 |
249 | young-adolescent | 1 |
250 | zoo-raised | 1 |
251 | ~12,000 | 1 |
252 | °c-carbonized | 1 |
1 | ~12,000 | 1 |
2 | 7,600 | 2 |
3 | 9650 | 2 |
4 | 2,370 | 3 |
5 | trial,80 | 1 |
6 | 27,111 | 1 |
7 | 275,831 | 1 |
8 | 1,541 | 5 |
9 | 14,641 | 4 |
10 | 3051 | 2 |
11 | 612,851 | 1 |
12 | 92,071 | 1 |
13 | 76,591 | 1 |
14 | b6cbf1 | 1 |
15 | 48,612 | 3 |
16 | 87,222 | 2 |
17 | 12,032 | 1 |
18 | 7052 | 3 |
19 | 29,592 | 1 |
20 | itt2 | 2 |
21 | 188,503 | 1 |
22 | 8923 | 2 |
23 | 3,533 | 2 |
24 | 2753 | 2 |
25 | 1,763 | 5 |
26 | 18,693 | 1 |
27 | 37,724 | 1 |
28 | 3734 | 3 |
29 | 6644 | 2 |
30 | 21,054 | 1 |
31 | 3154 | 4 |
32 | 3274 | 3 |
33 | 2774 | 6 |
34 | 8584 | 2 |
35 | 67,784 | 1 |
36 | 4594 | 3 |
37 | 1,894 | 3 |
38 | 4,425 | 2 |
39 | 28045 | 1 |
40 | 8245 | 3 |
41 | 20,165 | 2 |
42 | 1,775 | 5 |
43 | 32:5 | 1 |
44 | 2,436 | 4 |
45 | 4,936 | 1 |
46 | 226,866 | 1 |
47 | 7,866 | 2 |
48 | 20,127 | 5 |
49 | 7,277 | 2 |
50 | 15/277 | 1 |
51 | 4777 | 4 |
52 | 5,887 | 8 |
53 | 5887 | 5 |
54 | 10,987 | 2 |
55 | 11,997 | 2 |
56 | 8808 | 2 |
57 | 5228 | 3 |
58 | 112528 | 1 |
59 | 51,048 | 1 |
60 | 19,368 | 2 |
61 | 4,778 | 2 |
62 | 9298 | 4 |
63 | 328,398 | 1 |
64 | 6109 | 1 |
65 | 18,409 | 1 |
66 | 2,909 | 2 |
67 | 19,439 | 1 |
68 | 12,639 | 1 |
69 | 7839 | 1 |
70 | 2,259 | 2 |
71 | 3,769 | 1 |
72 | 5699 | 1 |
73 | head-trauma | 2 |
74 | bedouin-arab | 1 |
75 | aht/hc | 1 |
76 | rigvedic | 1 |
77 | intersubspecific | 2 |
78 | hyperphagic | 9 |
79 | non-dysphagic | 2 |
80 | nonsystolic | 2 |
81 | asthenozoospermic | 10 |
82 | aphasic | 46 |
83 | hepatolithiatic | 3 |
84 | psychoneurotic | 2 |
85 | pair-bonded | 1 |
86 | short-necked | 3 |
87 | self-labeled | 1 |
88 | infirmed | 1 |
89 | bladder-drained | 15 |
90 | neutered | 40 |
91 | practitioner-referred | 2 |
92 | zoo-raised | 1 |
93 | noncircumcised | 4 |
94 | non-immunised | 3 |
95 | new-diagnosed | 1 |
96 | bpa-exposed | 9 |
97 | arsenic-exposed | 3 |
98 | flutamide-exposed | 2 |
99 | statin-exposed | 2 |
100 | non-immune-suppressed | 2 |
101 | unpremedicated | 18 |
102 | e2-treated | 11 |
103 | non-ma-treated | 2 |
104 | lasercomb-treated | 5 |
105 | baipc-treated | 2 |
106 | glyburide-treated | 6 |
107 | eptifibatide-treated | 4 |
108 | aripiprazole-treated | 20 |
109 | lamotrigine-treated | 2 |
110 | anthracycline-treated | 9 |
111 | fluvoxamine-treated | 4 |
112 | nicotine-treated | 7 |
113 | desvenlafaxine-treated | 8 |
114 | nnk-treated | 3 |
115 | trimethoprim-treated | 1 |
116 | deslorelin-treated | 3 |
117 | penicillin-treated | 10 |
118 | bradykinin-treated | 2 |
119 | cyclosporin-treated | 4 |
120 | silodosin-treated | 5 |
121 | doxazosin-treated | 3 |
122 | combination-treated | 6 |
123 | ozp-treated | 3 |
124 | adr-treated | 3 |
125 | cbt-treated | 4 |
126 | ht-treated | 2 |
127 | efv-treated | 6 |
128 | conventionally-treated | 3 |
129 | community-treated | 3 |
130 | clopidogrel-pretreated | 1 |
131 | preirradiated | 3 |
132 | mechanically-ventilated | 11 |
133 | infibulated | 4 |
134 | crc-affected | 1 |
135 | influenza-infected | 12 |
136 | hiv/hcv-co-infected | 3 |
137 | hrv-infected | 2 |
138 | volume-depleted | 2 |
139 | government-accredited | 1 |
140 | medicare-supported | 1 |
141 | formalin-preserved | 5 |
142 | deinstitutionalized | 1 |
143 | non-organized | 2 |
144 | °c-carbonized | 1 |
145 | lung-anesthetized | 1 |
146 | propofol-anesthetized | 2 |
147 | non-paralyzed | 3 |
148 | 1-d-old | 61 |
149 | 21-d-old | 10 |
150 | 42-d-old | 3 |
151 | one-d-old | 9 |
152 | 3-4-month-old | 1 |
153 | 6-8-month-old | 1 |
154 | 6-week-old | 23 |
155 | 8-week-old | 26 |
156 | three-week-old | 5 |
157 | five-week-old | 5 |
158 | four-week-old | 11 |
159 | eight-week-old | 21 |
160 | 32-wk-old | 2 |
161 | 6-wk-old | 7 |
162 | 7-wk-old | 5 |
163 | 8-wk-old | 5 |
164 | 8.5-year-old | 1 |
165 | 14-16-year-old | 4 |
166 | eighteen-year-old | 1 |
167 | 81-yr-old | 1 |
168 | 18-28-yr-old | 1 |
169 | 76-years-old | 1 |
170 | 82-y-old | 1 |
171 | 30-day-old | 4 |
172 | 180-day-old | 1 |
173 | 75-day-old | 1 |
174 | 6-day-old | 1 |
175 | one-day-old | 80 |
176 | eighty-day-old | 1 |
177 | blackface | 3 |
178 | heart-failure-free | 1 |
179 | antidepressant-free | 12 |
180 | women-safe | 2 |
181 | people.the | 2 |
182 | children.the | 3 |
183 | cap.the | 1 |
184 | persons.unlike | 1 |
185 | age-eligible | 16 |
186 | screen-eligible | 2 |
187 | restricting-type | 3 |
188 | mother-perinate | 1 |
189 | kaiser-permanente | 4 |
190 | semi-acute | 3 |
191 | methotrexate-naive | 11 |
192 | anti-tnf-naive | 2 |
193 | non-naive | 2 |
194 | normotensive/pre-hyptertensive | 1 |
195 | m/z-negative | 1 |
196 | diarrhea-positive | 1 |
197 | se-positive | 3 |
198 | marker-positive | 12 |
199 | lhbt-positive | 4 |
200 | m/z-positive | 1 |
201 | hbeag-seropositive | 1 |
202 | kaf | 4 |
203 | spf/vaf | 1 |
204 | 886-g | 1 |
205 | tg-misiir-tag | 4 |
206 | 240-kg | 3 |
207 | 55-kg | 3 |
208 | employment-seeking | 1 |
209 | non-binge-drinking | 3 |
210 | cannabis-using | 4 |
211 | non-vomiting | 3 |
212 | late-presenting | 5 |
213 | pasteurizing | 6 |
214 | first-ami | 1 |
215 | 129s1/svimj | 2 |
216 | daywork | 2 |
217 | low-uti-risk | 2 |
218 | 3.5-wk | 1 |
219 | non-tribal | 3 |
220 | agonadal | 2 |
221 | premenarcheal | 5 |
222 | diatel | 9 |
223 | demand.all | 1 |
224 | groups.all | 2 |
225 | 425-gram | 1 |
226 | africanamerican | 1 |
227 | archean | 5 |
228 | chinese-han | 6 |
229 | sardinian | 15 |
230 | bilaterian | 2 |
231 | white-asian | 2 |
232 | draw-a-man | 1 |
233 | exercise.fourteen | 1 |
234 | dorn | 1 |
235 | model+no | 1 |
236 | met30-ttr-fap | 1 |
237 | sham-group | 2 |
238 | dysvascular | 1 |
239 | freiberger | 1 |
240 | solid-tumor | 7 |
241 | adult | 15,480 |
242 | subadult | 4 |
243 | noninfant | 2 |
244 | young-adolescent | 1 |
245 | adult/adolescent | 4 |
246 | non-steroid-dependent | 2 |
247 | ncct-deficient | 1 |
248 | overnight-abstinent | 2 |
249 | palest | 1 |
250 | low-accuracy | 1 |
251 | trauma-injury | 1 |
252 | children® | 1 |